HCPCS Level IIdrugActive
J1598
Inj glycopyrrolate fres kabi
BETOS: O1E
Effective: 2025-01-01
Description
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Glycopyrrolate Injection
Manufacturer
FreseniUS Kabi USA, LLC
HCPCS Dosage
0.1 MG
Billing Units
6.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.